Researcher

Xue He

China Academy of Chinese Medical Sciences

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 17, 2026 · JOURNAL ARTICLE

Mortality and cardiovascular risk of triglyceride-glucose and derived indices in cardiovascular-kidney-metabolic syndrome stages 0-3: a dose-response meta-analysis

Frontiers in Endocrinology

Rigorous meta-analysis of 80 observational studies with dose-response modelling, clear effect sizes and confidence intervals, but observational design and surrogate indices limit practice-changing status.

Strong EvidenceJun-Qiao An Qian-Ying Hao Chronic Kidney Disease and Diabetes

Reported

TyG-WC and CVD mortality (highest…RR = 1.52, 95% CI: 1.35–1.70, 95% PI: 1.26–…

CTI and incident CVDRR = 1.57, 95% CI: 1.33–1.85, 95% PI: 1.00–…

TyG-BMI and incident CVDRR = 1.51, 95% CI: 1.36–1.67, 95% PI: 1.05–…

AUG 7, 2026 · REVIEW

Neoadjuvant therapy combined with immunotherapy for anal sphincter preservation rate, clinical efficacy, and safety in rectal cancer patients: a meta-analysis

Frontiers in Oncology

Meta-analysis of 16 predominantly single-arm studies (540 patients) reports favorable pooled proportions for sphincter preservation (90%) and R0 resection (98%), but evidence is low-to-moderate certainty without direct RCT comparisons; confirmatory trials needed.

PromisingWenkang Zhang Bladder and Urothelial Cancer Treatments Colorectal Cancer Surgical Treatments

Reported

Sample size540

Number of studies16

Anal sphincter preservation rate…0.90